{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:27:53Z","timestamp":1772126873078,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.anpede.2026.504088","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T20:28:20Z","timestamp":1770496100000},"page":"504088","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adverse events after COVID-19 vaccination in the pediatric population in Spain"],"prefix":"10.1016","volume":"104","author":[{"given":"M. \u00c1ngeles","family":"Rivas Paterna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"P\u00e9rez Ingidua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana B.","family":"Rivas Paterna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ortega Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Aleo Luj\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Vargas Castrill\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpede.2026.504088_bib0005","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-052335","article-title":"Parents\u2019 intentions and perceptions about COVID-19 vaccination for their children: results from a national survey","volume":"148","author":"Szilagyi","year":"2021","journal-title":"Pediatrics."},{"key":"10.1016\/j.anpede.2026.504088_bib0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.anpedi.2022.04.008","article-title":"Posiciones de las sociedades de Pediatr\u00eda frente a la vacunaci\u00f3n infantil contra la COVID-19","volume":"97","author":"Gallegos","year":"2022","journal-title":"An Pediatr (Barc)."},{"key":"10.1016\/j.anpede.2026.504088_bib0015","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.15585\/mmwr.mm705152a1","article-title":"COVID-19 vaccine safety in children aged 5\u201311 years \u2014 United States, November 3\u2013December 19, 2021","volume":"70","author":"Hause","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.anpede.2026.504088_bib0020","first-page":"24","article-title":"International heterogeneity in coronavirus disease 2019 pediatric mortality rates","volume":"78","author":"Gonz\u00e1lez-Garc\u00eda","year":"2021","journal-title":"Bol Med Hosp Infant Mex."},{"key":"10.1016\/j.anpede.2026.504088_bib0025","first-page":"401.e1","article-title":"Grupo de Trabajo de Pediatr\u00eda Basada en la Evidencia de la AEP y AEPap. COVID-19 en pediatr\u00eda: valoraci\u00f3n cr\u00edtica de la evidencia","volume":"94","author":"Gonz\u00e1lez Rodr\u00edguez","year":"2021","journal-title":"An Pediatr (Barc)."},{"key":"10.1016\/j.anpede.2026.504088_bib0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ccm.2022.11.014","article-title":"SARS-CoV-2 Infection and COVID-19 in Children","volume":"44","author":"Waghmare","year":"2023","journal-title":"Clin Chest Med."},{"key":"10.1016\/j.anpede.2026.504088_bib0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jama.2021.23262","article-title":"Multisystem inflammatory syndrome in children by COVID-19 vaccination status of adolescents in France","volume":"327","author":"Levy","year":"2021","journal-title":"JAMA."},{"key":"10.1016\/j.anpede.2026.504088_bib0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.15585\/mmwr.mm7102e1","article-title":"Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12-18 years - United States, July-December 2021","volume":"71","author":"Zambrano","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.anpede.2026.504088_bib0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2116298","article-title":"Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age","volume":"386","author":"Walter","year":"2022","journal-title":"N Engl J Med."},{"key":"10.1016\/j.anpede.2026.504088_bib0050","unstructured":"Comit\u00e9 asesor de Vacunas e Inmunizaci\u00f3n de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Recomendaciones actualizadas del Ministerio de Sanidad para la vacunaci\u00f3n contra la COVID-19 en 2024-2025 [accessed 18 Jul 2025]. Available from: https:\/\/vacunasaep.org\/profesionales\/noticias\/vacunacion-de-la-covid-19-2024-25-recomendaciones-actualizadas-del-ministerio."},{"key":"10.1016\/j.anpede.2026.504088_bib0055","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Comirnaty Omicron XBB.1.5 30. Ficha t\u00e9cnica. [Internet]. Madrid: AEMPS; 2023 [accessed 18 Jul 2025]. Available from: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/1201528024\/FT_1201528024.html."},{"key":"10.1016\/j.anpede.2026.504088_bib0060","first-page":"57511","article-title":"Real Decreto 577\/2013 de 26 de julio por el que se regula la farmacovigilancia de medicamentos de uso humano","volume":"179","year":"2013","journal-title":"Bolet\u00edn Ofic del Estado."},{"key":"10.1016\/j.anpede.2026.504088_bib0065","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cpt1977213247","article-title":"Toward the operational identification of adverse drug reactions","volume":"21","author":"Karch","year":"1977","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.anpede.2026.504088_bib0070","first-page":"233","article-title":"Methods of monitoring adverse reactions to drugs","volume":"21","author":"Venulet","year":"1977","journal-title":"Prog Drug Res."},{"key":"10.1016\/j.anpede.2026.504088_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"REDCap Consortium, The REDCap consortium: building an international community of software partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform."},{"key":"10.1016\/j.anpede.2026.504088_bib0080","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-057313","article-title":"Safety of COVID-19 vaccination in United States children ages 5 to 11 years","volume":"150","author":"Hause","year":"2022","journal-title":"Pediatrics."},{"key":"10.1016\/j.anpede.2026.504088_bib0085","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1001\/jama.2021.5374","article-title":"Reactogenicity following receipt of mRNA-based COVID-19 vaccines","volume":"325","author":"Chapin-Bardales","year":"2021","journal-title":"JAMA."},{"key":"10.1016\/j.anpede.2026.504088_bib0090","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jamapediatrics.2022.6243","article-title":"Assessment of efficacy and safety of mRNA COVID-19 vaccines in children aged 5 to 11 years: a systematic review and meta-analysis","volume":"177","author":"Watanabe","year":"2023","journal-title":"JAMA Pediatr."}],"container-title":["Anales de Pediatr\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287926000189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287926000189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:33:37Z","timestamp":1772123617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2341287926000189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2341287926000189"],"URL":"https:\/\/doi.org\/10.1016\/j.anpede.2026.504088","relation":{},"ISSN":["2341-2879"],"issn-type":[{"value":"2341-2879","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse events after COVID-19 vaccination in the pediatric population in Spain","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpede.2026.504088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2025.504088","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"504088"}}